[go: up one dir, main page]

EA200800144A1 - МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ - Google Patents

МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ

Info

Publication number
EA200800144A1
EA200800144A1 EA200800144A EA200800144A EA200800144A1 EA 200800144 A1 EA200800144 A1 EA 200800144A1 EA 200800144 A EA200800144 A EA 200800144A EA 200800144 A EA200800144 A EA 200800144A EA 200800144 A1 EA200800144 A1 EA 200800144A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cspcna
isoforms
modifications
application
identifying
Prior art date
Application number
EA200800144A
Other languages
English (en)
Other versions
EA013109B1 (ru
Inventor
Дерек Дж. Хоуэлз
Роберт Дж. Хикки
Линда Х. Малкас
Original Assignee
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн filed Critical Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн
Publication of EA200800144A1 publication Critical patent/EA200800144A1/ru
Publication of EA013109B1 publication Critical patent/EA013109B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • G01N33/5758—

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Insulating Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Раскрывают способы и композиции для выявления присутствия csPCNA изоформы посредством идентифицирования одной или нескольких посттрансляционных модификаций. Раскрывают способы идентифицирования csPCNA изоформы через посредство посттрансляционных модификаций, включая уровни метилэстерификации.
EA200800144A 2005-06-27 2006-06-26 МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ EA013109B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69415905P 2005-06-27 2005-06-27
PCT/US2006/024774 WO2007002574A2 (en) 2005-06-27 2006-06-26 Cspcna isoform modifications and uses thereof

Publications (2)

Publication Number Publication Date
EA200800144A1 true EA200800144A1 (ru) 2008-06-30
EA013109B1 EA013109B1 (ru) 2010-02-26

Family

ID=37116243

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800144A EA013109B1 (ru) 2005-06-27 2006-06-26 МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ

Country Status (11)

Country Link
US (2) US7932023B2 (ru)
EP (1) EP1899373B1 (ru)
JP (1) JP5090344B2 (ru)
CN (1) CN101258161A (ru)
AT (1) ATE504598T1 (ru)
AU (1) AU2006261856B2 (ru)
BR (1) BRPI0611703A2 (ru)
CA (1) CA2612695A1 (ru)
DE (1) DE602006021178D1 (ru)
EA (1) EA013109B1 (ru)
WO (1) WO2007002574A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2638866C (en) 2006-02-17 2015-11-10 Indiana University Research And Technology Corporation Peptide based inhibition of capcna protein-protein interactions in cancer
AU2009273873A1 (en) * 2008-07-24 2010-01-28 Indiana University Research And Technology Corporation Cancer peptide therapeutics
US20120258482A1 (en) * 2009-10-09 2012-10-11 Indiana University Research And Technology Corporation Pcna methyltransferase
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
WO2012173677A2 (en) * 2011-03-23 2012-12-20 Indiana University Research And Technology Corporation Anticancer therapeutic agents
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
TW202411650A (zh) * 2018-02-01 2024-03-16 美商再生元醫藥公司 治療性單株抗體之品質屬性的定量及模型化

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294471B2 (en) * 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen

Also Published As

Publication number Publication date
WO2007002574A3 (en) 2007-05-03
HK1112928A1 (en) 2008-09-19
WO2007002574A2 (en) 2007-01-04
DE602006021178D1 (de) 2011-05-19
JP5090344B2 (ja) 2012-12-05
US20110195510A1 (en) 2011-08-11
CN101258161A (zh) 2008-09-03
EP1899373B1 (en) 2011-04-06
EA013109B1 (ru) 2010-02-26
JP2008547034A (ja) 2008-12-25
CA2612695A1 (en) 2007-01-04
US7932023B2 (en) 2011-04-26
EP1899373A2 (en) 2008-03-19
BRPI0611703A2 (pt) 2011-12-20
AU2006261856B2 (en) 2012-07-05
AU2006261856A1 (en) 2007-01-04
ATE504598T1 (de) 2011-04-15
US20090061432A1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
EA200702643A1 (ru) Антитела, связывающие tweak
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA200701918A1 (ru) Белок липокалин
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
EA201100300A1 (ru) Композиции и способы, предназначенные для направленного воздействия антител на белок c5 системы комплемента
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
NO20060202L (no) Pyrrolodihydroisokinoliner som PDE-10-inhibitorer
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
DK1776011T3 (da) Fungicid sammensætning, indeholdende et syreamidderivat
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
CR10280A (es) Anticuerpos de la efgl7 y metodos de uso
EA200702529A1 (ru) Фунгицидная комбинация биологически активных веществ
ATE483000T1 (de) Naphtalin-amidin-imide
DK1987357T3 (da) Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf
PA8667201A1 (es) Nuevos compuestos farmaceuticos
EA200702352A1 (ru) Новые композиции нутрицевтиков
DE602005011416D1 (de) Schnell härtende polydiorganosiloxane
EA200800144A1 (ru) МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ
ATE430148T1 (de) Neue pyrrolodihydroisochinoline als pde10- inhibitoren

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU